Rebase Rada OÜ

Active Registry code 16368759 OÜ Tartu linn Registered 17 Nov 2021
Compare

Rebase Rada OÜ is a OÜ based in Tartu linn, registry code 16368759, status: active. Main activity: Other human health activities n.e.c.. Its annual report for 2025 shows revenue of €1 450 and 0 employees.

Revenue
1 450 €
↑ 314.3% vs 2024
Employees
0
±0 vs 2024

2025 · annual report, e-Äriregister

Position in the industry Human health activities · EMTAK 86

  • Revenue · 2025 1 450 €
    industry median 20 811 € · companies in the industry: 3 373
  • Net profit margin · 2025 43.1 %
    industry median 8.3 % · companies in the industry: 2 759

Taxes and turnover

No tax data available. EMTA publishes data for those who paid state taxes, filed a VAT return or had employees in the quarter. New and small companies may be missing.

Financials by year

2022 – 2025
Revenue, € 2025: 1 450 € · +314.3% vs 2024 · industry median 20 811 € · above 25% of the industry
05 00010 00015 00020 00025 0002022 Company: 0 € Industry median: 20 030 €20222023 Company: 0 € Industry median: 19 469 €20232024 Company: 350 € Industry median: 20 000 €20242025 Company: 1 450 € Industry median: 20 811 €202505 00010 00015 00020 00025 0002022 Company: 0 € Industry median: 20 030 €2023 Company: 0 € Industry median: 19 469 €20232024 Company: 350 € Industry median: 20 000 €2025 Company: 1 450 € Industry median: 20 811 €2025
  • Company
  • Industry median

Industry: Human health activities (the EMTAK division of the main activity). Median: half of the industry is above, half below.

Net profit, € 2025: 625 € · +396.0% vs 2024 · industry median 1 071 € · above 46% of the industry
05001 0001 5002 0002022 Company: 0 € Industry median: 1 525 €20222023 Company: 0 € Industry median: 1 745 €20232024 Company: 126 € Industry median: 1 621 €20242025 Company: 625 € Industry median: 1 071 €202505001 0001 5002 0002022 Company: 0 € Industry median: 1 525 €2023 Company: 0 € Industry median: 1 745 €20232024 Company: 126 € Industry median: 1 621 €2025 Company: 625 € Industry median: 1 071 €2025
  • Company
  • Industry median

Industry: Human health activities (the EMTAK division of the main activity). Median: half of the industry is above, half below.

Net profit margin, % 2025: 43.1 % · industry median 8.3 % · above 85% of the industry
010203040502022 Company: — Industry median: 11.3 %20222023 Company: — Industry median: 11.4 %20232024 Company: — Industry median: 10.7 %20242025 Company: 43.1 % Industry median: 8.3 %2025010203040502022 Company: — Industry median: 11.3 %2023 Company: — Industry median: 11.4 %20232024 Company: — Industry median: 10.7 %2025 Company: 43.1 % Industry median: 8.3 %2025
  • Company
  • Industry median

Industry: Human health activities (the EMTAK division of the main activity). Median: half of the industry is above, half below.

Assets, € 2025: 851 € · −21.3% vs 2024
02505007501 0001 2502022 Company: 0 €20222023 Company: 0 €20232024 Company: 1 081 €20242025 Company: 851 €202502505007501 0001 2502022 Company: 0 €2023 Company: 0 €20232024 Company: 1 081 €2025 Company: 851 €2025
Equity, € 2025: 851 € · +161.0% vs 2024
02004006008001 0002022 Company: 0 €20222023 Company: 0 €20232024 Company: 326 €20242025 Company: 851 €202502004006008001 0002022 Company: 0 €2023 Company: 0 €20232024 Company: 326 €2025 Company: 851 €2025
Employees 2025: 0 · industry median 2 · above 2% of the industry
0.00.51.01.52.02022 Company: 0 Industry median: 220222023 Company: 0 Industry median: 220232024 Company: 0 Industry median: 220242025 Company: 0 Industry median: 220250.00.51.01.52.02022 Company: 0 Industry median: 22023 Company: 0 Industry median: 220232024 Company: 0 Industry median: 22025 Company: 0 Industry median: 22025
  • Company
  • Industry median

Industry: Human health activities (the EMTAK division of the main activity). Median: half of the industry is above, half below.

Financials by year
Year Revenue, € Net profit, € Labour costs, € Assets, € Equity, € Employees
2025 1 450 625 0 851 851 0
2024 350 126 0 1 081 326 0
2023 0 0 0 0 0 0
2022 0 0 0 0 0 0

Figures from the company’s own (non-consolidated) balance sheet and income statement. A loss is shown with a minus sign.

Financial ratios for 2025

Net profit margin
43.1 %
Net profit / revenue
Return on equity (ROE)
73.4 %
Net profit / equity
Return on assets (ROA)
73.4 %
Net profit / assets
Equity ratio
100.0 %
Equity / assets
Debt ratio
0.0 %
Liabilities / assets

Annual reports

PDFs from e-Äriregister
Annual reports
Year Period Filed Report Documents
2025 1 Jan 2025 – 31 Dec 2025 17 Jun 2026 Company’s own e-Äriregister
2024 1 Jan 2024 – 31 Dec 2024 3 Jun 2025 Company’s own e-Äriregister
2023 1 Jan 2023 – 31 Dec 2023 28 Jun 2024 Company’s own e-Äriregister
2022 17 Nov 2021 – 31 Dec 2022 30 Jun 2023 Company’s own e-Äriregister

Board

Right of representation

Any member of the management board may represent the private limited company in all transactions.

Owners

Beneficial owners

  • Kristel Laiuste
    Member of a senior management body (management or supervisory board) · since 17 Jun 2026
  • Gert Laiuste
    Direct ownership · since 17 Nov 2021

Founders and other persons

shared board members, owners or beneficial owners

Activities (EMTAK)

  • 86992Other human health activities n.e.c. Main
Rulings
Number, date Title Deadline State Document
Ä 50188729 / 7
2 Jun 2025
Amendment entry In force
2 Jun 2025
PDF
Ä 50188729 / 6
20 Dec 2024
Amendment entry In force
20 Dec 2024
PDF
Ä 50188729 / M1
18 Dec 2024
Ruling to eliminate deficiencies 17 Jan 2025 Deficiencies eliminated
20 Dec 2024
PDF
Ä 50188729 / 5
13 Nov 2024
Entry refused In force
28 Oct 2024
PDF
Ä 50188729 / 4
13 Nov 2024
Amendment entry In force
13 Nov 2024
PDF
Ä 50188729 / 3
6 Sep 2024
Entry refused In force
24 Sep 2024
PDF
Ä 50188729 / 2
1 Sep 2023
Amendment entry In force
1 Sep 2023
PDF
Ä 50188729
17 Nov 2021
First entry In force
17 Nov 2021
PDF

Sources: e-Äriregister and EMTA. Data updated 31 Oct 2026. Open at the source ↗ · Report an error in the data